ArticleStem cell research & therapy2024

Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring.

Mithun Santra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.